Search for: "Mylan Pharmaceuticals"
Results 541 - 560
of 739
Sorted by Relevance
|
Sort by Date
24 Jun 2019, 10:00 pm
Mylan Pharmaceuticals, Inc., 896 F.3d 1322 (Fed. [read post]
28 Sep 2016, 8:39 am
Amgen Inc., et al., No. 16-332 (effectively extending exclusivity to 12 1/2 years; complement to the Sandoz petition) Mylan Pharmaceuticals, et al. v. [read post]
27 Oct 2010, 3:38 am
Abbott (EPLAW) Lunesta (Eszopiclone) – US: Cobalt Pharmaceuticals and Sepracor settle Lunesta patent litigation (Patent Docs) Mirapex (Pramipexole) – US: Mylan receives approval for generic version of Mirapex tablets (SmartBrief) Oracea (Doxycyline) – US: Mylan seeks declaratory judgment of non-infringement and invalidity based on ANDA filing: Mylan v Galderma (Patent Docs) Perlane, Restylane (Hyaluronic acid) – US: Genzyme files patent… [read post]
9 Dec 2009, 3:59 pm
Teva Pharmaceuticals USA Inc. [read post]
20 May 2009, 5:18 am
(IP tango) China: China IP forum to bring third patent amendment face-to-face with biotechnology concerns (PatentlyBIOtech) France: Patent and SPC status searches on the INPI website (The SPC Blog) India: Government republishes controversial report on patentability of pharmaceuticals and microorganisms (Managing Intellectual Property) India: The pharmaceutical patent debate: wither drug safety? [read post]
18 Feb 2010, 10:34 am
Mylan followed Sandoz Pharmaceuticals Corp. v. [read post]
4 May 2011, 4:13 am
Purepac Pharmaceutical, et. al. [read post]
19 Apr 2011, 5:04 pm
Highlights this week included: Aricept (Donepezil HCI) – US: Lawsuit alleges false marking based on Orange Book ‘advertising’: Pharmaceutical Technologies v Eisai (FDA Law Blog) (Patent Docs) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
31 May 2011, 8:38 pm
General WIPO SCP16: Joint proposal of the African Group and the Development Agenda Group on a work program on Patents and Health (Knowledge Ecology International) Rogue pharmacies slide under Google radar (IP Osgoode) Australia slips further out-of-step on pharmaceutical extensions (Patentology) EU: Proposed EU Customs Regulation may not dispel fear of wrongful drug seizures (IP Watch) EU: Karl De Gucht writes Andris Piebalgs on topic of European Union IPR demands on India and other… [read post]
24 Aug 2011, 12:33 am
USPTO (Patent Docs) US: ALJ Rogers sets procedural schedule in Certain Coenzyme Q10 (337-TA-790) (ITC 337 Law Blog) Products Actos (Pioglitazone) – Brazil: STJ rules against extension of patent related to Actos (IP tango) Frova (Frovatriptan) – US: Endo Pharmaceuticals files patent infringement complaint against Mylan in response to Para IV certification filing (Patent Docs) Gemzar (Gemcitabine) – US: ALJ Rogers grants motion to terminate investigation in… [read post]
9 Sep 2009, 7:14 am
(America-Israel Patent Law) USPTO says some requests for patent term adjustment reconsideration are premature (Patent Docs) US: New York Times article ‘For Profit, Industry Seeks Cancer Drugs’ reports on cancer drug development (Patent Docs) Products Angiomax (Bivalirudin) – US: Last-minute extension of pharmaceutical product life, or just throwing up a smokescreen? [read post]
13 Mar 2019, 9:10 am
Mylan Pharmaceuticals, Inc., et al., No. 18-899 (May tribal sovereign immunity may be asserted to bar IPR review of patents owned by the tribe?) [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs) Products Ablify (Aripiprazole) - US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) - US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) - US: Teva files amended complaint against Momenta/Sandoz to include infringement of three Copaxone-related patents… [read post]
29 Jul 2010, 10:24 am
’s (“Caraco”) and Sun Pharmaceutical Laboratories, Ltd. [read post]
1 Apr 2013, 8:29 am
” Upon receiving this reissue patent, Pfizer immediately filed a lawsuit against Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Lupin Pharmaceuticals, USA, Inc.; Apotex Corp.; and Apotex, Inc. in the United States District Court for the Eastern District of Virginia for infringement of the reissue patent. [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs) Products Ablify (Aripiprazole) - US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) - US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) - US: Teva files amended complaint against Momenta/Sandoz to include infringement of three Copaxone-related patents… [read post]
6 Jan 2010, 3:32 am
’ (The SPC Blog) India: Reviewing the Indian Patent Regime after 5 years of the introduction of the pharmaceutical product patent regime (Spicy IP) UK: Department of Health proposing generic prescription drugs option (GenericsWeb) US: 7th Circuit: Enforcing contracts between joint owners: Wisconsin Alumni Research Foundation (WARF) v. [read post]
31 May 2012, 7:50 am
Mylan Pharmaceuticals, Inc., Mylan, Inc. [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
18 May 2011, 12:33 am
Sun Pharmaceuticals on question of obviousness-type double patenting (Patent Docs) (IPBiz) Glumetza (Metformin) – US: Depomed receives notice of Para IV certification against patents from second ANDA filer, Sun Pharmaceutical (GenericsWeb) Myfortic7 (Mycophenolate) – US: Novartis files patent infringement complaint against Teva in response to Para IV certification filing (Patent Docs) NuvaRing (Etonogestrel, Estradiol) – US: ALJ Luckern sets procedural schedule in… [read post]
